Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced NSCLC × Nivolumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 44 Carcinoma, Non-Small-Cell Lung 41 Carcinoma, Renal Cell 32 Colorectal Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 16 Urinary Bladder Neoplasms 15 Neoplasms 15 Neoplasm Metastasis 15 Stomach Neoplasms 14 Lung Neoplasms 14 Pancreatic Neoplasms 13 Sarcoma 11 Ovarian Neoplasms 11 Hodgkin Disease 10 Carcinoma, Transitional Cell 10 Carcinoma, Hepatocellular 10 Rectal Neoplasms 9 Glioblastoma 9 Small Cell Lung Carcinoma 8 Prostatic Neoplasms 8 Head and Neck Neoplasms 8 Triple Negative Breast Neoplasms 7 Kidney Neoplasms 7 Esophageal Neoplasms 7 Colonic Neoplasms 7 Breast Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 6 Brain Neoplasms 6 Skin Neoplasms 5 Lymphoma, Follicular 5

Interventions

Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡